全文获取类型
收费全文 | 2542篇 |
免费 | 305篇 |
国内免费 | 21篇 |
专业分类
耳鼻咽喉 | 12篇 |
儿科学 | 68篇 |
妇产科学 | 31篇 |
基础医学 | 189篇 |
口腔科学 | 81篇 |
临床医学 | 411篇 |
内科学 | 661篇 |
皮肤病学 | 39篇 |
神经病学 | 142篇 |
特种医学 | 317篇 |
外科学 | 196篇 |
综合类 | 22篇 |
预防医学 | 321篇 |
眼科学 | 15篇 |
药学 | 142篇 |
肿瘤学 | 221篇 |
出版年
2023年 | 51篇 |
2022年 | 17篇 |
2021年 | 25篇 |
2020年 | 48篇 |
2019年 | 29篇 |
2018年 | 67篇 |
2017年 | 48篇 |
2016年 | 63篇 |
2015年 | 74篇 |
2014年 | 116篇 |
2013年 | 141篇 |
2012年 | 68篇 |
2011年 | 93篇 |
2010年 | 83篇 |
2009年 | 103篇 |
2008年 | 82篇 |
2007年 | 105篇 |
2006年 | 83篇 |
2005年 | 67篇 |
2004年 | 72篇 |
2003年 | 40篇 |
2002年 | 44篇 |
2001年 | 47篇 |
2000年 | 49篇 |
1999年 | 50篇 |
1998年 | 79篇 |
1997年 | 98篇 |
1996年 | 91篇 |
1995年 | 67篇 |
1994年 | 73篇 |
1993年 | 61篇 |
1992年 | 44篇 |
1991年 | 41篇 |
1990年 | 49篇 |
1989年 | 71篇 |
1988年 | 54篇 |
1987年 | 61篇 |
1986年 | 61篇 |
1985年 | 52篇 |
1984年 | 33篇 |
1983年 | 30篇 |
1982年 | 38篇 |
1981年 | 40篇 |
1980年 | 19篇 |
1979年 | 21篇 |
1978年 | 16篇 |
1977年 | 20篇 |
1976年 | 22篇 |
1975年 | 17篇 |
1974年 | 18篇 |
排序方式: 共有2868条查询结果,搜索用时 31 毫秒
101.
102.
103.
Impact of Breast Density Legislation on Breast Cancer Risk Assessment and Supplemental Screening: A Survey of 110 Radiology Facilities
下载免费PDF全文
![点击此处可从《The breast journal》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Lina Nayak MD Kanae K. Miyake MD PhD Jessica W. T. Leung MD Elissa R. Price MD Yueyi I. Liu MD PhD Bonnie N. Joe MD PhD Edward A. Sickles MD William R. Thomas MD Jafi A. Lipson MD Bruce L. Daniel MD Jonathan Hargreaves MD R. James Brenner MD JD Lawrence W. Bassett MD Haydee Ojeda‐Fournier MD Karen K. Lindfors MD MPH Stephen A. Feig MD Debra M. Ikeda MD 《The breast journal》2016,22(5):493-500
Breast density notification laws, passed in 19 states as of October 2014, mandate that patients be informed of their breast density. The purpose of this study is to assess the impact of this legislation on radiology practices, including performance of breast cancer risk assessment and supplemental screening studies. A 20‐question anonymous web‐based survey was emailed to radiologists in the Society of Breast Imaging between August 2013 and March 2014. Statistical analysis was performed using Fisher's exact test. Around 121 radiologists from 110 facilities in 34 USA states and 1 Canadian site responded. About 50% (55/110) of facilities had breast density legislation, 36% of facilities (39/109) performed breast cancer risk assessment (one facility did not respond). Risk assessment was performed as a new task in response to density legislation in 40% (6/15) of facilities in states with notification laws. However, there was no significant difference in performing risk assessment between facilities in states with a law and those without (p < 0.831). In anticipation of breast density legislation, 33% (16/48), 6% (3/48), and 6% (3/48) of facilities in states with laws implemented handheld whole breast ultrasound (WBUS), automated WBUS, and tomosynthesis, respectively. The ratio of facilities offering handheld WBUS was significantly higher in states with a law than in states without (p < 0.001). In response to breast density legislation, more than 33% of facilities are offering supplemental screening with WBUS and tomosynthesis, and many are performing formal risk assessment for determining patient management. 相似文献
104.
Using CollaboRATE,a brief patient‐reported measure of shared decision making: Results from three clinical settings in the United States
下载免费PDF全文
![点击此处可从《Health expectations》网站下载免费的PDF全文](/ch/ext_images/free.gif)
105.
To optimally demonstrate the value of risk management, our actions must show the benefits. The American Society for Healthcare Risk Management (ASHRM) board needs to provide support through tools and resources. ASHRM members must show through their actions the value of risk management. And ASHRM members need to show the organization where actions and activities should be focused in the future. Actions show the value of enterprise risk management. 相似文献
106.
107.
Pedersen KE Buckner CK Meeker SN Undem BJ 《The Journal of pharmacology and experimental therapeutics》2000,292(1):319-325
The effect of selective tachykinin receptor agonists and antagonists on human isolated intralobar pulmonary arterial rings was investigated. Neither Substance P (SP) nor neurokinin A (NKA) contracted the arteries. Both of these agonists, however, were potent and efficacious at relaxing the arteries that were precontracted with phenylephrine. The negative log (M) EC(50) values for SP and NKA were 9.0 and 8.3, respectively. The neurokinin (NK)-3 selective agonist, senktide-analog, and the NK-2 receptor selective agonist, [beta-Ala(8)]NKA(4-10), caused neither contractions nor relaxations of the arteries, whereas the NK-1 receptor agonist Ac-[Arg6, Sar9, Met(O2)11]SP(6-11) (ASM-SP) relaxed the tissue with a potency similar to SP. The relaxations to SP, NKA, and ASM-SP were competitively antagonized by the selective NK-1 receptor antagonist CP 99994, with a pK(b) in the nanomolar range. Antagonism of the ASM-SP-induced relaxations was also noted with FK 888, RP 67580, and L 732,138, although these antagonists were much less potent than CP 99994 in this regard. Another NK-1 receptor selective antagonist, SR 140333, caused an insurmountable antagonism of the SP-induced relaxations. The NK-1 receptor-mediated relaxations could be blocked by removing the endothelium, or by a combination of N-nitro-L-arginine and indomethacin. Measurement of prostanoid generation revealed that in endothelial-intact but not endothelial-denuded tissue, ASM-SP caused a selective increase in the production of 6-keto-PGF1alpha, the stable metabolite of prostacyclin. The results indicate that stimulation of NK-1 receptors leads to relaxation of human intralobar pulmonary arteries, which is mediated largely by nitric oxide and prostacyclin released from the endothelium of these vessels. 相似文献
108.
109.
110.